Publicaciones en colaboración con investigadores/as de Università dell'Insubria (25)

2024

  1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

    Blood Advances, Vol. 8, Núm. 18, pp. 4950-4959

2023

  1. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score

    Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 818-829

  2. Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

    Blood, Vol. 140, Núm. 16, pp. 1764-1773

  3. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

    ESMO Open, Vol. 7, Núm. 2

  4. Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study

    Interactive Cardiovascular and Thoracic Surgery, Vol. 35, Núm. 1

  5. Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

    Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566

  6. Prognostic role of standard uptake value according to pathologic features of lung adenocarcinoma

    Tumori, Vol. 108, Núm. 5, pp. 461-469

2021

  1. Egg consumption and cardiovascular risk: a dose–response meta-analysis of prospective cohort studies

    European Journal of Nutrition, Vol. 60, Núm. 4, pp. 1833-1862

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database

    Journal of Surgical Oncology, Vol. 123, Núm. 2, pp. 560-569

  4. Survival and quality of life after early discharge in low-risk pulmonary embolism

    European Respiratory Journal, Vol. 57, Núm. 2

2020

  1. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial

    European Heart Journal, Vol. 41, Núm. 4, pp. 509-518

  2. Ethical criteria for the admission and management of patients in the icu under conditions of limited medical resources: A shared international proposal in view of the covid-19 pandemic

    Frontiers in Public Health, Vol. 8

  3. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

    The Lancet Haematology, Vol. 7, Núm. 10, pp. e746-e755

  4. Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: A propensity-matched analysis

    International Journal of Gynecological Cancer, Vol. 30, Núm. 7, pp. 987-992

  5. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 8, pp. 1940-1951

2019

  1. Adherence to the Mediterranean diet and risk of stroke and stroke subtypes

    European Journal of Epidemiology, Vol. 34, Núm. 4, pp. 337-349

  2. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  3. Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129](S1359610117301089)(10.1016/j.cytogfr.2017.06.010)

    Cytokine and Growth Factor Reviews